Literature DB >> 15477658

Association of intracellular proteins with folded major histocompatibility complex class I molecules.

Chantey R Morris1, Adrian J Reber, Jason L Petersen, Shanna E Vargas, Joyce C Solheim.   

Abstract

The major histocompatibility complex (MHC) class I molecule is responsible for presenting peptide antigens at the cell surface for recognition by cytotoxic T lymphocytes. Several chaperone molecules interact with the MHC class I heavy chain and release when the MHC groove folds around peptide. Two additional proteins, invariant chain and amyloid precursor-like protein 2 (APLP2), interact specifically and stably with MHC class I molecules that have folded peptide-binding grooves. Invariant chain and APLP2 also affect MHC class I cell-surface expression, and so may play a part in MHC class I trafficking. Association of APLP2 with the MHC class I molecule appears to be regulated by a viral protein, the adenovirus E3/19K protein. Analysis of the interactions of these proteins with each other and with MHC class I will clarify how presentation of antigens by MHC class I is controlled by events that occur subsequent to MHC class I folding.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15477658     DOI: 10.1385/IR:30:2:171

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  62 in total

1.  Cutting edge: adenovirus E19 has two mechanisms for affecting class I MHC expression.

Authors:  E M Bennett; J R Bennink; J W Yewdell; F M Brodsky
Journal:  J Immunol       Date:  1999-05-01       Impact factor: 5.422

2.  Monoclonal antibodies raised against denatured HLA-B locus heavy chains permit biochemical characterization of certain HLA-C locus products.

Authors:  N J Stam; H Spits; H L Ploegh
Journal:  J Immunol       Date:  1986-10-01       Impact factor: 5.422

3.  Exogenous peptide ligand influences the expression and half-life of free HLA class I heavy chains ubiquitously detected at the cell surface.

Authors:  B M Carreno; T H Hansen
Journal:  Eur J Immunol       Date:  1994-06       Impact factor: 5.532

4.  Identification of amino acids within the MHC molecule important for the interaction with the adenovirus protein E3/19K.

Authors:  D Feuerbach; S Etteldorf; C Ebenau-Jehle; J P Abastado; D Madden; H G Burgert
Journal:  J Immunol       Date:  1994-08-15       Impact factor: 5.422

5.  Reduced allorecognition of adenovirus-2 infected cells.

Authors:  M Andersson; A McMichael; P A Peterson
Journal:  J Immunol       Date:  1987-06-01       Impact factor: 5.422

6.  Frequency of abnormal expression of HLA-A,B,C and HLA-DR molecules, invariant chain, and LFA-3 (CD58) in colorectal carcinoma and its impact on tumor recurrence.

Authors:  P Möller; K Koretz; P Schlag; F Momburg
Journal:  Int J Cancer Suppl       Date:  1991

7.  Insertion of the adenoviral E3 region into a recombinant viral vector prevents antiviral humoral and cellular immune responses and permits long-term gene expression.

Authors:  Y Ilan; G Droguett; N R Chowdhury; Y Li; K Sengupta; N R Thummala; A Davidson; J R Chowdhury; M S Horwitz
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

8.  HLA class II antigen expression in human papillomavirus-associated cervical cancer.

Authors:  S S Glew; M Duggan-Keen; T Cabrera; P L Stern
Journal:  Cancer Res       Date:  1992-07-15       Impact factor: 12.701

9.  The amyloid precursor-like protein 2 and the adenoviral E3/19K protein both bind to a conformational site on H-2Kd and regulate H-2Kd expression.

Authors:  Chantey R Morris; Jason L Petersen; Shanna E Vargas; Heth R Turnquist; Mary M McIlhaney; Sam D Sanderson; Joseph T Bruder; Yik Y L Yu; Hans-Gerhard Burgert; Joyce C Solheim
Journal:  J Biol Chem       Date:  2002-12-27       Impact factor: 5.157

10.  A short sequence in the COOH-terminus makes an adenovirus membrane glycoprotein a resident of the endoplasmic reticulum.

Authors:  S Pääbo; B M Bhat; W S Wold; P A Peterson
Journal:  Cell       Date:  1987-07-17       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.